伊卢丁S抑制p53-Mdm2相互作用,在结直肠癌中具有抗癌功效
Yoonsuk Lee1, Yun Young Lee2, Jinyoung Park3
1Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|December 31, 2024
概括
伊卢丁S通过抑制p53-Mdm2相互作用来激活p53通路. 这种新的方法对p53向癌症疗法具有前景,在结直肠癌模型中显示出抗癌作用.
科学领域:
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
- 药物发现 药物发现 药物发现
背景情况:
- 由于p53蛋白质的结构,对于瘤抑制至关重要的p53通路在历史上一直是具有挑战性的治疗目标.
- 尽管面临挑战,但对基于p53的疗法的重新兴趣正在推动针对癌症治疗的新策略的研究.
- 在p53通路内确定有效的点仍然是开发成功的p53点疗法的重要障碍.
研究的目的:
- 使用分子查系统发现p53通路的新型激活剂.
- 阐明伊卢丁S的作用机制,这种化合物具有已知的抗癌作用,但机制不清楚.
- 通过准p53-Mdm2相互作用来评估伊卢丁S作为结直肠癌的潜在治疗剂.
主要方法:
- 采用分子选系统来识别激活p53通路的化合物.
- 研究Illudin S与p53的相互作用及其对p53-Mdm2复合体的影响.
- 在体外研究中评估了伊卢丁S对p53稳定性,转录活性,细胞亡和结直肠癌细胞细胞循环停止的影响 (CT26).
- 在体内研究评估了Illudin S在结直肠癌小鼠模型中的疗效.
主要成果:
- 伊卢丁S被确定为p53-Mdm2相互作用的新型抑制剂.
- 伊卢丁S直接与p53上的Mdm2结合部位结合,增强p53的稳定性和转录活性.
- 通过伊卢丁S抑制p53-Mdm2相互作用,增加了p53的表达,诱导了细胞亡,并在CT26细胞中引起细胞循环停止.
- 在大肠直肠癌小鼠模型中,Illudin S的使用显著抑制了瘤生长和延长了生存时间.
结论:
- 伊卢丁S有效地向p53-Mdm2相互作用,为其在结直肠癌中的抗癌作用提供了机制性解释.
- 伊卢丁S作为p53向癌症治疗的p53激活剂,显示出显著的治疗潜力.
- 伊卢丁S的进一步开发可能会导致针对各种癌症的新型治疗策略.
更多相关视频
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K